Referencias:

• Schenker, J.G., Weinstein, D., Ovarian hypestimulation syndrome: a current survey (1978) Fertil Steril, 30, pp. 255-268
• Ishikawa, K., Ohba, T., Tanaka, N., Iqbal, M., Okamura, Y., Okamura, H., Organ-specific production control of vascular endothelial growth factor in ovarian hyperstimulation syndrome-model rats (2003) Endocrinol J, 50, pp. 515-525
• Gómez, R., Simón, C., Remohí, J., Pellicer, A., Administration of moderate and high doses of gonadotropins to female rats increases ovarian vascular endothelial growth factor (VEGF) and VEGF receptor-2 expression that is associated to vascular hyperpermeability (2003) Biol Reprod, 68, pp. 2164-2171
• Brinsden, P.R., Wada, I., Tan, S.L., Balen, A., Jacobs, H.S., Diagnosis, prevention and management of ovarian hyperstimulation syndrome (1995) Br J Obstet Gynaecol, 102, pp. 767-772
• Abramov, Y., Barae, V., Nisman, B., Schenker, J.G., Vascular endothelial growth factor plasma levels correlate to the clinical picture in severe ovarian hyperstimulation syndrome (1997) Fertil Steril, 67, pp. 261-265
• Gaytán, M., Bellido, C., Morales, C., Sánchez-Criado, J.E., Gaytán, F., Effects of selective inhibition of cyclooxygenase and lipooxygenase pathways in follicle rupture and ovulation in the rat (2006) Reproduction, 132, pp. 571-577
• Gómez, R., Simón, C., Remohí, J., Pellicer, A., Vascular endothelial growth factor receptor-2 (VEGFR-2) activation induces vascular permeability in hyperstimulated rats and this effect is prevented by receptor blockade (2002) Endocrinology, 142, pp. 4339-4348
• Houck, K.A., Ferrara, N., Winer, J., Cachianes, G., Li, B., Leung, D.W., The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA (1991) Mol Endocrinol, 5, pp. 1806-1814
• Bacic, M., Edwards, N.A., Merrill, M.J., Differential expression of vascular endothelial growth factor (vascular permeability factor) forms in rat tissues (1995) Growth Factors, 12, pp. 11-15
• Burchardt, M., Burchardt, T., Chen, M.W., Shabsigh, A., de la Taille, A., Buttyan, R., Expression of messenger ribonucleic acid splice variants for vascular endothelial growth factor in the penis of adults rats and humans (1999) Biol Reprod, 60, pp. 398-404
• Iijima, K., Jiang, J.Y., Shimizu, T., Sasada, H., Sato, E., Acceleration of follicular development by administration of vascular endothelial growth factor in cycling female rats (2005) J Reprod Dev, 51, pp. 61-68
• Larrivee, B., Karsan, A., Signalling pathways induced by vascular endothelial growth factor (review) (2000) Int J Mol Med, 5, pp. 447-456
• Kendall, R.L., Wang, G., Thomas, K.A., Identification of a natural soluble form of the vascular endothelial growth factor receptor, FLT-1, and its heterodimerization with KDR (1996) Biochem Biophys Res Commun, 226, pp. 324-328
• Tsujii, M., Kawano, S., Tsuji, S., Sawaoka, H., Hori, M., DuBois, R.N., Cyclooxigenase regulates angiogenesis induced by colon cancer cells (1998) Cell, 93, pp. 705-716
• Liu, X.H., Kirschenbaum, A., Yao, S., Lee, S., Holland, J.F., Levine, A.C., Inhibition of cyclooxygenase-2 suppresses angiogenesis and the growth of prostate cancer in vivo (2000) J Urol, 164, pp. 820-825
• Liu, X.H., Kirschenbaum, A., Lu, M., Yao, S., Dosoretz, A., Holland, J.F., Prostaglandin E2 induces hypoxia-inducible factor-1 alpha stabilization and nuclear localization in a human prostate cancer cell line (2002) J Biol Chem, 277, pp. 50081-50086
• Ozcakir, H.T., Giray, S.G., Ozbilgin, M.K., Inceboz, U.S., Caglar, H., Effect of angiotensin-converting enzyme-inhibiting therapy on the expression of vascular endothelial growth factor in hyperstimulated rat ovary (2004) Fertil Steril, 82 (SUPPL. 3), pp. 1127-1132
• Lee, A., Burry, K.A., Christenson, L.K., Patton, P.E., Stouffer, R.L., Vascular endothelial growth factor levels in serum and follicular fluid of patients undergoing in vitro fertilization (1997) Fertil Steril, 68, pp. 305-311
• Laschke, M.W., Elitzsch, A., Scheuer, C., Vollmar, B., Menger, M.D., Selective cyclo-oxygenase-2 inhibition induces regression of autologous endometrial grafts by down-regulation of vascular endothelial growth factor-mediated angiogenesis and stimulation of caspase-3-dependent apoptosis (2007) Fertil Steril, 87, pp. 163-171
• Bata, M.S., Al-Ramahi, M., Salhab, A.S., Gharaibeh, M.N., Schwartz, J., Delay of ovulation by Meloxicam in healthy cycling volunteers: a placebo-controlled, double-blind, crossover study (2006) J Clin Pharmacol, 46, pp. 925-932
• Davis, B.J., Lennard, D.E., Lee, C.A., Tiano, H.F., Morham, S.G., Wetsel, W.G., Anovulation in cyclooxygenase-2 deficient mice is restored by prostaglandin E2 and interleukin-1 beta (1999) Endocrinology, 140, pp. 2685-2695
• Lee, J.S., Choi, Y.D., Lee, J.H., Nam, J.H., Choi, C., Lee, M.C., Expression of cyclooxygenase-2 in epithelial ovarian tumors and its relation to vascular endothelial growth factor and p53 expression (2006) Int J Gynecol Cancer, 16 (SUPPL. 1), pp. 247-253
• Stavreus-Evers, A., Koraen, L., Scott, J.E., Zhang, P., Westlund, P., Distribution of cyclooxygenase-1, cyclooxygenase-2, and cytosolic phospholipase A2 in the luteal phase human endometrium and ovary (2005) Fertil Steril, 83, pp. 156-162
• Salhab, A.S., Gharaibeh, M.N., Shomaf, M.S., Amro, B.I., Meloxicam inhibits rabbit ovulation (2001) Contraception, 63, pp. 329-333
• Norman, R.J., Wu, R., The potential danger of COX-2 inhibitors (2004) Fertil Steril, 81, pp. 493-494
• Noble, S., Balfour, J.A., Meloxicam (1996) Drugs, 51, pp. 424-432
• Flower, R.J., The development of COX2 inhibitors (2003) Nat Rev Drug Discovery, 2, pp. 179-191

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------